AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Image Source : Krish Capital Pty Ltd
Index Update: The S&P/ASX 200 Index slipped 8.40 points to close at 8,550.80 on Thursday, marking a marginal decline. Over the past five sessions, the benchmark has risen 0.32% but remains 1.02% below its 52-week high. Sectoral performance was mixed, with seven of the 11 sectors ending the day in negative territory. Health Care emerged as the top performer, advancing 0.48% on the day and 0.50% over the five-day period.
Macro Update: Household wealth in Australia rose 0.8% (AUD 137.1 billion) in the March quarter 2025, driven by a 1.2% (AUD 125.3 billion) increase in residential land and dwelling values, according to the Australian Bureau of Statistics (ABS). This property value growth contributed approximately 0.7 percentage points to overall wealth gains. However, national investment fell by AUD 21.7 billion to AUD 157.7 billion, with general government investment declining by AUD 3.2 billion to AUD 25.9 billion due to reduced capital formation across all levels of government. In labour market trends, job vacancies rose 2.9% to 339,400 in May 2025, rebounding after a decline recorded in the February quarter.
Top Market Movers: Top gainers on the ASX included Clarity Pharmaceuticals (ASX: CU6), which surged 14.35% to close at AUD 2.39, followed by Iluka Resources (ASX: ILU), up 6.88% to AUD 3.73, and Neuren Pharmaceuticals (ASX: NEU), rising 6.14% to AUD 13.31. On the downside, Xero (ASX: XRO) dropped 5.26% to AUD 184.00, while Sigma Healthcare (ASX: SIG) and Nick Scali (ASX: NCK) fell 3.83% and 3.45%, respectively.
Commodity Update: The U.S. dollar slipped to a 3.5-year low against the euro on Thursday amid concerns over the Federal Reserve's independence. Reports suggested President Trump should consider replacing Fed Chair Jerome Powell, which shook investor confidence. Gold rose 0.36% to USD 3,355.20, silver gained 0.55% to USD 36.31, and copper added 0.54% to USD 9,782.00. Brent crude climbed 0.20% to USD 67.80, supported by strong U.S. demand and Middle East ceasefire uncertainties.
Our Stance: The ASX 200’s slight dip of 8.40 points reflects short-term consolidation amid mixed sectoral trends and cautious investor sentiment. Encouragingly, job vacancies rose 2.9% in May, and household wealth saw a 0.8% lift in Q1 2025, supported by property value gains—signaling resilience in consumer fundamentals. However, falling national investment and broader global uncertainty, including U.S. monetary policy concerns, suggest ongoing volatility.
The S&P/ASX 200 index faced a challenging trading session, closing down by 8.40 points, forming a small bearish candlestick pattern, and accompanied by increased trading volume. However, the index remains above the 50-period Simple Moving Average (SMA), which now serves as a critical support level. On the daily chart, there is significant support around the 8,460.50 mark, making it a key level for market participants to watch. If the index can maintain its position above this support level, it could help solidify recent gains and instill greater confidence in the market’s upward trajectory. Additionally, the index is trading above the 21-period SMA on the weekly chart, which is a positive sign for potential sustained momentum in the longer term. The alignment of technical indicators across both daily and weekly timeframes provides a bullish outlook, suggesting that the index may demonstrate resilience against market fluctuations and has the potential for continued upward movement, provided it holds above key support levels.
This article has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine. Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate to your objectives, financial situation and needs before acting upon it. There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product. Please note past performance is neither an indicator nor a guarantee of future performance. You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice/information in this article or on the Kalkine website. Not all investments are appropriate for all people. The information in this article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its articles, newsletters and websites. All information represents our views at the date of publication and may change without notice. Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this article, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law. Please also read our Terms & Conditions and Financial Services Guide for further information. On the date of publishing this article (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures. Some of the images/music that may be used in the article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the article unless stated otherwise. The images/music that may be used in the article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary. Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Please wait processing your request...